World-renowned hematologist Brian G.M. Durie, MD, has died at the age of 82. Dr. Durie’s death was announced on October 14, 2025, in a press release by the International Myeloma Foundation (IMF), which Dr. Durie co-founded in 1990.
“Dr. Durie was a giant in the field like no other. He leaves behind a legacy that will endure forever—from his incredible contributions to myeloma research to the superb care and counseling he provided patients; from educating almost all practicing myeloma experts today to helping advance patient care through important clinical trials; from developing the Durie-Salmon Staging System to co-founding the IMF, a patient-centered organization, which he led for three decades. He had an enormous impact—not just on myeloma but on all of oncology. I have lost a dear friend and mentor and will forever cherish his kindness,” said IMF Chairperson of the Board S. Vincent Rajkumar, MD.
Dr. Durie was born in December 1942 in Gullane, Scotland. He graduated from the University of Edinburgh Medical School in 1966 and moved to the United States to complete his medical residency and subspecialty training at the Mayo Clinic in Minnesota. In 1989, he became a professor and Head of the Department of Clinical and Laboratory Hematology at the University of London, where he also established a myeloma program. In 1992, he returned to the United States in the Division of Hematology/Oncology at Cedars-Sinai Medical Center in Los Angeles, where he served as a myeloma specialist physician, according to the IMF.
Dr. Durie is survived by his wife, Susie Durie, his daughter, Annabel Reardon, and his son, Benjamin Durie, along with his four grandchildren. Those wishing contact the family may contact Annabel Reardon at [email protected].
